Incidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications
Author:
Open Access
- 1 April 2010
- journal article
- research article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 4, 203-209
Abstract
Peer reviewed article authored by (Takeo Fukuchi, Kimiko Wakai, Kieko Suda, et al). Read article or submit your manuscript for publishing.Keywords
This publication has 31 references indexed in Scilit:
- Prevalence of Ocular Surface Disease in Glaucoma PatientsJournal of Glaucoma, 2008
- Travoprost 0.004% With and Without Benzalkonium Chloride: A Comparison of Safety and EfficacyJournal of Glaucoma, 2007
- The Safety and Intraocular Pressure–Lowering Efficacy of Brimonidine Tartrate 0.15% Preserved with Polyquaternium-1Ophthalmology, 2006
- In Vitro Study of Inflammatory Potential and Toxicity Profile of Latanoprost, Travoprost, and Bimatoprost in Conjunctiva-Derived Epithelial CellsInvestigative Ophthalmology & Visual Science, 2005
- The Efficacy and Safety of Dose Escalation of Dorzolamide Used in Combination with Other Topical Antiglaucoma AgentsJournal of Ocular Pharmacology and Therapeutics, 2003
- Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cellsCurrent Eye Research, 2000
- Comparison of 24 hour control with Timoptic ® 0.5% and Timoptic‐XE TM 0.5% in exfoliation and primary open‐angle glaucomaActa Ophthalmologica Scandinavica, 1999
- Effect of topical beta blockers on corneal epithelial wound healing in the rabbit.British Journal of Ophthalmology, 1994
- Adverse effects of topical antiglaucomatous medications on the conjunctiva.British Journal of Ophthalmology, 1993
- Effects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivity.British Journal of Ophthalmology, 1990